Deep Neural Networks in image processing, predictive modelling and diagnostic decisions
Posted 2nd September 2020 by Liv Sewell
Now more than ever intelligent human beings are needed to fulfil high value and high complexity tasks and histopathology is no exception. In fact, it is one of the sectors in the most desperate need.
Pricing Pressure, Payer Perspectives and Innovative Diagnostic Platforms
Posted 24th August 2018 by Jane Williams
We spoke to Alex Bastian about how he got started in precision medicine, where he sees it going and how he intends to use real world evidence to unlock the potential around personalised approaches to drug development:
Busting Common Myths about Quantitative PCR & Digital PCR
Posted 4th June 2018 by Jane Williams
qPCR and dPCR are mature analytical methods for quantifying selected genetic materials in a sample. Both utilise the PCR method to amplify amounts as small as a single molecular fragment (template) to levels where they can be easily detected, usually by fluorescence techniques.
The Big List of Quantitative PCR & Digital PCR Companies & Investors
Posted 30th May 2018 by Jane Williams
The global qPCR & dPCR instrumentation market is growing and is expected to reach 1631.09 million USD by the end of 2025[1].
Connecting Cancer Biology to Clinical Oncology: Still a World to Win
Posted 14th May 2018 by Jane Williams
Our understanding of the aberrant biological pathways (oncogenic pathways) that are involved in the formation and progression of cancers has increased with huge leaps in the last decades of cancer research. The ever-increasing knowledge was and still is accompanied by the development of increasing numbers of precision drugs, tailored to neutralize these aberrations.